Derivados de piperidinona como inhibidores de MDM2 para el tratamiento de cáncer
El compuesto ácido 2-((3R,5R,6S)-5-(3-clorofenil)-6-(4-clorofenil)-1-((S)-1-(isopropilsulfonil)-3-metilbutan-2-il)-3 -metil-2-oxopiperidin-3-il)acético, o una sal farmacéuticamente aceptable del mismo. The present invention provides MDM2 inhibitor compounds of Formula IE,which compounds are useful a...
Saved in:
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | Spanish |
Published |
15.07.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | El compuesto ácido 2-((3R,5R,6S)-5-(3-clorofenil)-6-(4-clorofenil)-1-((S)-1-(isopropilsulfonil)-3-metilbutan-2-il)-3 -metil-2-oxopiperidin-3-il)acético, o una sal farmacéuticamente aceptable del mismo.
The present invention provides MDM2 inhibitor compounds of Formula IE,which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor. |
---|---|
Bibliography: | Application Number: ES20110726581T |